Table of Content

Chapter 1 Preface 

1.1 Report description

1.2 Research methodology 

1.3 Assumptions

 

Chapter 2 Market synopsis 

 

Chapter 3 Porter’s five forces analysis 

3.1 Bargaining power of suppliers

3.2 Bargaining power of buyers

3.3 Threat of new entrants 

3.4 Threat of substitutes 

3.5 Intensity of rivalry 

 

Chapter 4 Industry overview 

4.1 Market definition

4.2 Market drivers 

      4.2.1 Growing applications of bioinformatics in drug discovery and development

      4.2.2 Growing information technology applications in bioinformatics 

      4.2.3 Increasing bioinformatics support in development of personalized medicines and clinical diagnostics 

      4.2.4 Bioinformatics support development of biomarkers for safer drugs 

      4.2.5 Rising need for integrated bioinformatics systems in proteomics and genomics 

4.3 Impact analysis of market drivers 

4.4 Market restraints 

      4.4.1 High cost and lack of skilled professionals

      4.4.2 Lack of interoperability among data formats

4.5 Impact analysis of market restraints 

4.6 Market trends

      4.6.1 Increasing number of mergers and acquisitions 

      4.6.2 Rising number of product innovations 

4.7 Market opportunities 

      4.7.1 Nanopore sequencing technology 

 

Chapter 5 Global market size and forecast 

 

Chapter 6 Market size and forecast by sector 

6.1 Medical biotechnology 

6.2 Gene therapy 

6.3 Academics 

6.4 Animal biotechnology 

6.5 Agriculture biotechnology 

6.6 Environmental biotechnology 

6.7 Forensic biotechnology 

 

Chapter 7 Market size and forecast by application

7.1 Genomics 

7.2 Chemoinformatics and drug design

7.3 Proteomics 

7.4 Transcriptomics 

7.5 Metabolomics 

7.6 Molecular phylogenomics

 

Chapter 8 Market size and forecast by tools and services 

8.1 Bioinformatics content / knowledge management tools

8.2 Bioinformatics platforms 

8.3 Bioinformatics services 

 

Chapter 9 Market size and forecast by geography

9.1 North America 

9.2 Europe 

9.3 Asia 

 

Chapter 10 Competitive scenario

10.1 Market share 

10.2 Competitive benchmarking 

 

Chapter 11 Company profiles 

11.1 Active Motif, Inc. 

      11.1.1 Company overview 

      11.1.2 Products & services 

      11.1.3 Financial performance 

      11.1.4 Recent developments

11.2 Illumina, Inc. 

      11.2.1 Company overview 

      11.2.2 Products & services 

      11.2.3 Financial performance 

      11.2.4 Recent developments 

11.3 Life Technologies 

      11.3.1 Company overview 

      11.3.2 Products & services 

      11.3.3 Financial performance 

      11.3.4 Recent developments 

11.4 Affymetrix, Inc.

      11.4.1 Company overview

      11.4.2 Products & services 

      11.4.3 Financial performance 

      11.4.4 Recent developments 

11.5 Agilent Technologies

      11.5.1 Company overview

      11.5.2 Products & services 

      11.5.3 Financial performance 

      11.5.4 Recent developments 

11.6 Bio-Rad Laboratories 

      11.6.1 Company overview 

      11.6.2 Products & services 

      11.6.3 Financial performance 

      11.6.4 Recent developments

11.7 QIAGEN 

      11.7.1 Company overview 

      11.7.2 Products & services 

      11.7.3 Financial performance 

      11.7.4 Recent developments 

11.8 Knome, Inc. 

      11.8.1 Company overview 

      11.8.2 Products & services 

      11.8.3 Financial performance 

      11.8.4 Recent developments 

11.9 GE Healthcare 

      11.9.1 Company overview 

      11.9.2 Products & Services 

      11.9.3 Financial Performance 

      11.9.4 Recent Developments 

11.10 Geneva Bioinformatics SA 

      11.10.1 Company overview 

      11.10.2 Products & services

      11.10.3 Financial performance

      11.10.4 Recent Developments 

11.11 Quest Diagnostics 

      11.11.1 Company overview 

      11.11.2 Products & services

      11.11.3 Financial performance

      11.11.4 Recent Developments